mylan-cyproterone / ethinylestradiol tablet
mylan pharmaceuticals ulc - cyproterone acetate; ethinyl estradiol - tablet - 2mg; 0.035mg - cyproterone acetate 2mg; ethinyl estradiol 0.035mg - other miscellaneous therapeutic agents
cyrotone-100 cyproterone acetate 100mg tablet bottle
strides pharma science pty ltd - cyproterone acetate, quantity: 100 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; croscarmellose sodium; povidone; magnesium stearate - inoperable prostatic carcinoma. to suppress flare with initial luteinising hormone releasing hormone (lhrh) analogue therapy; in long-term palliative treatment where lhrh analogues or surgery are ineffective, not tolerated, contraindicated or where oral therapy is preferred; in the treatment of hot flushes in patients treated with lhrh analogues or who have had orchidectomy.
cyrotone-100 cyproterone acetate 100mg tablet blister pack
strides pharma science pty ltd - cyproterone acetate, quantity: 100 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; croscarmellose sodium; povidone; magnesium stearate - inoperable prostatic carcinoma. to suppress flare with initial luteinising hormone releasing hormone (lhrh) analogue therapy; in long-term palliative treatment where lhrh analogues or surgery are ineffective, not tolerated, contraindicated or where oral therapy is preferred; in the treatment of hot flushes in patients treated with lhrh analogues or who have had orchidectomy.
cyproterone acetate 50mg tablets
stragen uk limited castle court 41, london road, reigate, surrey, rh2prj, united kingdom - cyproterone acetate - tablet - cyproterone acetate 50 mg - sex hormones and modulators of the genital system
anterone 100 cyproterone acetate 100mg tablet blister pack
cipla australia pty ltd - cyproterone acetate, quantity: 100 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; maize starch; pregelatinised maize starch; lactose monohydrate; magnesium stearate; povidone - inoperable prostatic carcinoma. to suppress 'flare' with initial luteinising hormone releasing hormone (lhrh) analogue therapy; in long-term palliative treatment where lhrh analogues or surgery are ineffective, not tolerated, contraindicated or where oral therapy is preferred; in the treatment of hot flushes in patients treated with lhrh analogues or who have had orchidectomy.
cyprone 100 cyproterone acetate 100mg tablet blister pack
alphapharm pty ltd - cyproterone acetate, quantity: 100 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; maize starch; pregelatinised maize starch; lactose monohydrate; magnesium stearate; povidone - inoperable prostatic carcinoma. to suppress 'flare' with initial luteinising hormone releasing hormone (lhrh) analogue therapy; in long-term palliative treatment where lhrh analogues or surgery are ineffective, not tolerated, contraindicated or where oral therapy is preferred; in the treatment of hot flushes in patients treated with lhrh analogues or who have had orchidectomy.
chelsea-35 ed cyproterone acetate 2 mg and ethinylestradiol 35 micrograms tablet blister pack
aspen pharma pty ltd - cyproterone acetate,ethinylestradiol -
cyproterone tablet
bdh inc. - cyproterone acetate - tablet - 50mg - cyproterone acetate 50mg - other miscellaneous therapeutic agents
cyprocur 100 cyproterone acetate 100mg tablet blister pack
aspen pharma pty ltd - cyproterone acetate -
laila-35 ed cyproterone acetate 2 mg and ethinylestradiol 35 micrograms tablet blister pack
aspen pharma pty ltd - cyproterone acetate,ethinylestradiol -